125I-MAb-425

N/A

Report date: 2025/09/11 11:16:08

Base Information

Drug Name125I-MAb-425
Drug Alias NameAnti-epidermal growth factor receptor monoclonal antibody 425MAb 425Monoclonal antibody 425MAB-425 radiolabeled with I-125EMD-55900
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Iodine > 125I +[4] 
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsAngiogenesis inhibitorsEpidermal growth factor inhibitors +[4] 
TargetsEpidermal growth factorEpidermal growth factor receptor erbB1P-glycoprotein 1
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDrexel University College of Medicine
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A